Page last updated: 2024-11-04

terbutaline and Migraine Disorders

terbutaline has been researched along with Migraine Disorders in 1 studies

Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.

Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)

Research Excerpts

ExcerptRelevanceReference
"Two pregnant patients with a history of migraine each developed evidence of cerebral ischemia while being treated with subcutaneous terbutaline, for asthma in one case and for tocolysis in the other."3.66Cerebral ischemia associated with parenteral terbutaline use in pregnant migraine patients. ( Benedetti, TJ; Featherstone, HJ; Rosene, KA, 1982)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rosene, KA1
Featherstone, HJ1
Benedetti, TJ1

Other Studies

1 other study available for terbutaline and Migraine Disorders

ArticleYear
Cerebral ischemia associated with parenteral terbutaline use in pregnant migraine patients.
    American journal of obstetrics and gynecology, 1982, Jun-15, Volume: 143, Issue:4

    Topics: Adult; Asthma; Female; Humans; Injections, Subcutaneous; Ischemic Attack, Transient; Migraine Disord

1982